IDNA | iShares Genomics Immunology and Healthcare ETF Overview

(Stock Exchange: AMEX)

Day's Range	20.18 - 20.52
52 Week Range	20.18 - 25.80
Beta	1.11
Implied Volatility	34.27%
IV Rank	42.01%
Day's Volume	18,994
Average Volume	32,359
Shares Outstanding	5,791,600
Inception Date	2019-06-14

Assets	138,185,670
Asset Class	Equity
Expense Ratio	0.47
P/E Ratio	22.27
EPS	0.92
Dividend Yield	0.56%
Dividend Per Share	0.11
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

*Chart delayed

Watching at IDNA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on IDNA Technicals page.